BM
RGNX icon

Brandywine Managers’s Regenxbio RGNX Stock Holding History

Brandywine Managers’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,900
Closed -$235K – 48
2021
Q1 		$235K Buy
6,900
+300
+5% +$12.8K 0.31% 44
2020
Q4 		$299K Buy
+6,600
New +$231K 0.41% 39
2020
Q3 		– Sell
-6,200
Closed -$228K – 43
2020
Q2 		$228K Hold
6,200
– – 0.94% 38
2020
Q1 		$201K Buy
6,200
+400
+7% +$16.7K 0.07% 34
2019
Q4 		$238K Hold
5,800
– – 0.07% 44
2019
Q3 		$206K Buy
5,800
+300
+5% +$12.2K 0.07% 45
2019
Q2 		$283K Buy
5,500
+600
+12% +$30K 0.11% 39
2019
Q1 		$281K Sell
4,900
-700
-13% -$34.7K 0.11% 42
2018
Q4 		$235K Buy
+5,600
New +$329K 0.11% 40

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brandywine Managers's RGNX Position: Q2 2021 in Review

Brandywine Managers sold out of Regenxbio (RGNX) in Q2 2021, closing a stake of 6,900 shares — an estimated $235K sold.

Brandywine Managers first reported a position in RGNX in Q4 2018 and held it in 9 quarters. The position peaked at $299K in Q4 2020. 172 funds tracked by Wall St. Rank hold RGNX as of Q2 2021.

  • Brandywine Managers reported no remaining Regenxbio position as of Q2 2021 after selling out during the quarter.
  • Brandywine Managers sold 6,900 Regenxbio shares in Q2 2021, an estimated $235K.
  • Brandywine Managers first reported a position in Regenxbio in Q4 2018 and held it in 9 quarters.
  • Brandywine Managers's Regenxbio position peaked at $299K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q2 2021.

Based on Brandywine Managers's 13F filing for Q2 2021, filed 16 Aug 2021.